Douglas S. Bireley Named Surgalign EVP Marketing and Research & Development

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

Douglas S. Bireley has been appointed Executive Vice President, Marketing and Research & Development of Surgalign, effective August 17, 2020. The news was announced today.

Douglas S. Bireley joins Surgalign with over 20 years of Spine experience in marketing and product development with a strong record of accomplishment in brand strategy, technology innovation, and business development. He has led marketing and R&D teams for a major Fortune 50 company and holds a Bachelor of Science degree in business administration from Bucknell University. Bireley will report directly to Terry Rich, President and Chief Executive Officer of Surgalign and will be based in San Diego, California.

“We are excited to welcome Doug as the final member of our best-in-class executive leadership team at Surgalign. I’m confident that his in-depth industry experience will further enhance our spine expertise, accelerate our efforts to build a leading marketing and R&D competency, and enhance our pace of innovation to advance care and improve patient outcomes,” said Rich.

Prior to joining Surgalign, Bireley was senior director of Global Strategic Marketing for Robotics & Digital Surgery at Johnson & Johnson. Bireley spent more than 20 years at Johnson & Johnson in various marketing and R&D roles of increasing responsibility, including leading the commercial integration of DePuy Spine and Synthes Spine.  He also has significant international experience including time spent living overseas.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles